Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001311859 | SCV001502199 | likely benign | not provided | 2020-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001477050 | SCV001681274 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2022-12-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001525299 | SCV001735358 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001525299 | SCV003863113 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004005058 | SCV004823058 | likely benign | Marfan syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |